Why the study?
Does postdischarge antithrombotic therapy reduce mortality and thromboembolic events in patients surviving intracerebral hemorrhage?
Population
6,369 patients surviving the first 30 days after hospitalization for first-time intracerebral hemorrhage…
Comparison
Postdischarge use of antithrombotic therapy. vs No use of antithrombotic therapy.
Design
Cohort
Follow-up
median 2.3 years
Authors
Loading...
OAC after ICH was associated with lower mortality and thromboembolism without excess bleeding; leaves open whether randomized trials will confirm net benefit.
Does postdischarge antithrombotic therapy reduce mortality and thromboembolic events in patients surviving intracerebral hemorrhage?
In patients surviving intracerebral hemorrhage who have an indication for anticoagulation, the use of oral anticoagulation therapy is associated with reduced mortality and thromboembolic events without a significant increase in major bleeding.
Ottosen et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: